Your browser doesn't support javascript.
loading
How much is too much? Threshold dose distributions for 5 food allergens.
Ballmer-Weber, Barbara K; Fernandez-Rivas, Montserrat; Beyer, Kirsten; Defernez, Marianne; Sperrin, Matthew; Mackie, Alan R; Salt, Louise J; Hourihane, Jonathan O'B; Asero, Riccardo; Belohlavkova, Simona; Kowalski, Marek; de Blay, Frédéric; Papadopoulos, Nikolaos G; Clausen, Michael; Knulst, André C; Roberts, Graham; Popov, Ted; Sprikkelman, Aline B; Dubakiene, Ruta; Vieths, Stefan; van Ree, Ronald; Crevel, René; Mills, E N Clare.
Afiliação
  • Ballmer-Weber BK; Allergy Unit, Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
  • Fernandez-Rivas M; Allergy Department, Hospital Clinico San Carlos, IdISSC, Madrid, Spain.
  • Beyer K; Department of Paediatric Pneumology and Immunology, Charité University Medical Center, Berlin, Germany.
  • Defernez M; Institute of Food Research, Norwich Research Park, Colney, Norwich, United Kingdom.
  • Sperrin M; Institute of Population Health, University of Manchester, Manchester, United Kingdom.
  • Mackie AR; Institute of Food Research, Norwich Research Park, Colney, Norwich, United Kingdom.
  • Salt LJ; Institute of Food Research, Norwich Research Park, Colney, Norwich, United Kingdom.
  • Hourihane JO; University College Cork, Cork, Ireland.
  • Asero R; Ambulatorio di Allergologia, Clinica San Carlo, Paderno-Dugnano, Milan, Italy.
  • Belohlavkova S; Faculty Hospital Bulovka, Department of Pediatrics, Prague, Czech Republic.
  • Kowalski M; Department of Immunology, Rheumatology and Allergy, Medical University of Lodz, Lodz, Poland.
  • de Blay F; Chest Disease Department, University Hospital, Federation of Translational Medicine, University of Strasbourg, Strasbourg, France.
  • Papadopoulos NG; Allergy Department, 2nd Pediatric Clinic, University of Athens, Athens, Greece.
  • Clausen M; Children's Hospital Iceland, Landspitali, University Hospital, Reykjavik, Iceland.
  • Knulst AC; University Medical Center Utrecht, Department of Dermatology/Allergology, Utrecht, The Netherlands.
  • Roberts G; Human Development and Health Academic Unit, University of Southampton Faculty of Medicine, Southampton, United Kingdom.
  • Popov T; Medical University, Clinical Centre of Allergology of the Alexandrovska Hospital, Sofia, Bulgaria.
  • Sprikkelman AB; Department of Pediatric Respiratory Medicine and Allergy, Emma Children's Hospital Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Dubakiene R; Chest Clinics, Allergology and Radiology, Medical Faculty, Vilnius University, Vilnius, Lithuania.
  • Vieths S; Paul Ehrlich Institute, Langen, Germany.
  • van Ree R; Department of Experimental Immunology and Department of Otorhinolaryngology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Crevel R; Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, United Kingdom.
  • Mills ENC; Institute of Food Research, Norwich Research Park, Colney, Norwich, United Kingdom; Institute of Inflammation and Repair, Manchester Academic Health Science Centre, Manchester Institute of Biotechnology, University of Manchester, Manchester, United Kingdom. Electronic address: clare.mills@manchester
J Allergy Clin Immunol ; 135(4): 964-971, 2015 Apr.
Article em En | MEDLINE | ID: mdl-25589011
ABSTRACT

BACKGROUND:

Precautionary labeling is used to warn consumers of the presence of unintended allergens, but the lack of agreed allergen thresholds can result in confusion and risk taking by patients with food allergy. The lack of data on threshold doses below which subjects are unlikely to react is preventing the development of evidence-based allergen management strategies that are understood by clinician and patient alike.

OBJECTIVE:

We sought to define threshold dose distributions for 5 major allergenic foods in the European population.

METHODS:

Patients with food allergy were drawn from the EuroPrevall birth cohort, community surveys, and outpatient clinic studies and invited to undergo a food challenge. Low-dose, double-blind, placebo-controlled food challenges were undertaken with commercially available food ingredients (peanut, hazelnut, celery, fish, and shrimp) blinded into common matrices. Dose distributions were modeled by using interval-censoring survival analysis with 3 parametric approaches.

RESULTS:

Of the 5 foods used for challenge, 4 produced similar dose distributions, with estimated doses eliciting reactions in 10% of the allergic population (ED10), ranging from 1.6 to 10.1 mg of protein for hazelnut, peanut, and celery with overlapping 95% CIs. ED10 values for fish were somewhat higher (27.3 mg of protein), although the CIs were wide and overlapping between fish and plant foods. Shrimp provided radically different dose distributions, with an ED10 value of 2.5 g of protein.

CONCLUSION:

This evidence base will contribute to the development of reference doses and action levels for allergens in foods below which only the most sensitive subjects might react.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Alérgenos / Hipersensibilidade Alimentar Tipo de estudo: Clinical_trials / Diagnostic_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adolescent / Adult / Child / Humans País/Região como assunto: Europa Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Alérgenos / Hipersensibilidade Alimentar Tipo de estudo: Clinical_trials / Diagnostic_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adolescent / Adult / Child / Humans País/Região como assunto: Europa Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Suíça